AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

CAS 1190392-22-3 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 1190392-22-3
Also known as: 1190392-22-3, (6s)-4-oxo-7,8-dihydro-6h-pyrrolo[1,2-a]pyrimidine-6-carboxylic acid, (6s)-4,6,7,8-tetrahydro-4-oxo-pyrrolo[1,2-a]pyrimidine-6-carboxylic acid, Schembl11964114, Ac3146, Akos037631126
Molecular Formula
C8H8N2O3
Molecular Weight
180.16  g/mol
InChI Key
VBGNTNJINOCQNQ-YFKPBYRVSA-N

1 2D Structure

CAS 1190392-22-3

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(6S)-4-oxo-7,8-dihydro-6H-pyrrolo[1,2-a]pyrimidine-6-carboxylic acid
2.1.2 InChI
InChI=1S/C8H8N2O3/c11-7-3-4-9-6-2-1-5(8(12)13)10(6)7/h3-5H,1-2H2,(H,12,13)/t5-/m0/s1
2.1.3 InChI Key
VBGNTNJINOCQNQ-YFKPBYRVSA-N
2.1.4 Canonical SMILES
C1CC2=NC=CC(=O)N2C1C(=O)O
2.1.5 Isomeric SMILES
C1CC2=NC=CC(=O)N2[C@@H]1C(=O)O
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 1190392-22-3

2. (6s)-4-oxo-7,8-dihydro-6h-pyrrolo[1,2-a]pyrimidine-6-carboxylic Acid

3. (6s)-4,6,7,8-tetrahydro-4-oxo-pyrrolo[1,2-a]pyrimidine-6-carboxylic Acid

4. Schembl11964114

5. Ac3146

6. Akos037631126

7. Zinc200989902

8. Cs-0083435

9. (6s)-4-oxo-4h,6h,7h,8h-pyrrolo[1,2-a]pyrimidine-6-carboxylic Acid

10. (6s)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxylic Acid

2.3 Create Date
2012-08-19
3 Chemical and Physical Properties
Molecular Weight 180.16 g/mol
Molecular Formula C8H8N2O3
XLogP3-0.8
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count1
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area70
Heavy Atom Count13
Formal Charge0
Complexity332
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
URL Supplier Web Content
1628836-08-7
Vibegron
JieJie Group Co., Ltd. is a pharmaceutical and chemical enterprise for research and production, it was bu...
JieJie Group Co., Ltd. is a pharmaceutical and chemical enterprise for research and production, it was built in 2009. Our core business is custom synthesis and contract manufacturing for advanced and bulk APIs, Pharmaceutical intermediates, water-soluble polymers, and special chemicals, from gram to multi tons scale. The company's aim is to be one of the reliable enterprises with the fastest development in the medicine industry in China and to become an impactive medicine enterprise entering the international authority market in the world.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
1628836-08-7
Vibegron
Jinan Shangbo Pharmaceutical Co., Ltd is a high-tech enterprise that specializes in the R&D, production, ...
Jinan Shangbo Pharmaceutical Co., Ltd is a high-tech enterprise that specializes in the R&D, production, and sales of pharmaceutical intermediates and fine chemicals, which was founded by Jinan Shengquan Group Share-holding Co., Ltd, and Biosynth Limited UK in 2011. Keeping up with the industrial development trend, Shangbo Pharm can provide all-directional services that from laboratory-level molecular design, synthesis, supply to customized synthesis, process development and commercial production of the crucial intermediates.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
1421271-01-3
Vibegron
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzh...
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
1628836-08-7
Vibegron
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzh...
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY